Sulfa in children.
Sulfa drugs are used in children for specific indications: urinary tract infection, MRSA skin and soft-tissue infection, Pneumocystis jirovecii pneumonia prophylaxis, and selected others. Pediatric prescribing is the work of the pediatrician — this site does not provide doses. The most important age caution is avoidance of sulfa antibiotics in newborns for kernicterus reasons.
- Common pediatric uses
- UTI, MRSA skin/soft tissue, PCP prophylaxis, toxoplasmosis (rare), occasional otitis (narrower role).
- Newborn caution
- Avoidance of sulfa antibiotics in the first weeks of life — kernicterus risk.
- Older infants and children
- Generally tolerated similarly to adults; allergy patterns are similar.
- Decisions
- Pediatrician — this site does not give doses.
The newborn caution
Sulfa antibiotics displace bilirubin from albumin-binding sites. In adults this rarely matters. In the newborn — particularly the preterm or low-birthweight neonate, with immature liver bilirubin handling — displacement can raise unconjugated bilirubin to levels that risk crossing into the brain and causing kernicterus, a permanent neurologic injury.
For this reason, sulfa antibiotics are generally avoided in the first weeks of life. Specific cut-offs vary by institution and by indication. The same concern shapes use in late pregnancy and is part of the rationale for caution in breastfeeding mothers of preterm or jaundiced newborns.
Older infants and children
Beyond the neonatal period, children tolerate sulfa antibiotics broadly similarly to adults. Common pediatric uses include:
Urinary tract infection. TMP-SMX remains an option for uncomplicated UTI in children, though local resistance patterns and pediatric guidelines shape choice. Cephalexin and other agents are also widely used.
MRSA skin and soft-tissue infection. TMP-SMX is one of several oral options for community-acquired MRSA infections in children, alongside clindamycin and (in some regions) doxycycline (limited by age in the very young because of dental considerations).
Pneumocystis jirovecii pneumonia prophylaxis. Standard in selected immunocompromised pediatric patients — particularly those receiving certain cancer chemotherapy regimens, post-transplant, or with HIV. TMP-SMX is the first-line agent.
Acute otitis media. Once a use; modern guidelines favour amoxicillin or amoxicillin-clavulanate as first-line, with TMP-SMX largely displaced for this indication.
Toxoplasmosis. Sulfadiazine + pyrimethamine + folinic acid is used in selected pediatric cases, particularly congenital toxoplasmosis treatment, by specialists.
Allergy in children
Children can develop sulfa antibiotic allergy as adults do; the most common pattern is a delayed maculopapular rash. Many "sulfa allergy" labels in adults date to a childhood reaction whose details have faded. Some of these labels are accurate; others reflect viral exanthems concurrent with antibiotic courses, GI side effects misread as allergy, or assumed family-pattern allergies.
Pediatric allergists in some centres run delabelling pathways for childhood drug-allergy labels of low concern, including sulfa antibiotics, with a goal of clarifying which children genuinely need to avoid the drug class. The mislabelled allergy covers the broader picture; diagnosis covers the assessment process.
Severe pediatric reactions — SJS/TEN, DRESS, anaphylaxis — are rare but recognised, and require urgent care exactly as in adults. Any child with such a reaction should have it documented prominently in their record, including drug, year, and reaction description.
G6PD deficiency in children
G6PD deficiency is more clinically apparent in children than in adults — neonatal jaundice and favism are common presentations. Children from populations with higher G6PD prevalence may be screened. Sulfa drugs (and dapsone, particularly) are managed accordingly.
Non-antibiotic sulfonamides in children
The non-antibiotic sulfonamides have specific pediatric indications. Furosemide is widely used in pediatric heart failure and edema. Thiazides are used in pediatric hypertension and in the prevention of calcium-containing kidney stones. Acetazolamide is used in some pediatric epilepsy and idiopathic intracranial hypertension. Each has age and dose considerations beyond the scope of this site.
Adolescents
Adolescents are generally treated as adults for sulfa prescribing purposes, with attention to pregnancy in adolescents who may be sexually active and to medication adherence. The same allergy considerations apply; the same indications are used. Topical sulfa preparations for acne (sulfacetamide, sometimes combined with sulfur) are used in adolescent dermatology in some settings.